The FDA cleared Neuralink to implant its brain chip in a second person, accepting the company’s proposed fixes for a problem that occurred in the first test participant.
China hinted at potential retaliation in response to the EU’s investigations into Chinese companies and launched an antidumping probe into chemical imports.
The Reserve Bank of Australia has warned that risks around the inflation outlook have risen, while uncertainty around the economy’s trajectory more broadly remains highly elevated.
